Acute Effects of Psilocybin on Attention and Executive Functioning in Healthy Volunteers: a Systematic Review and Multilevel Meta-analysis

Overview

Journal Psychopharmacology (Berl)

Date 2025 Jan 23

PMID 39847068

Authors

P Yousefi

Morten P Lietz

F J OHiggins

R C A Rippe

G Hasler

M van Elk

S Enriquez-Geppert

Affiliations

Soon will be listed here.

Abstract

Rationale: Psilocybin shows promise for treating neuropsychiatric disorders. However, insight into its acute effects on cognition is lacking. Given the significant role of executive functions in daily life and treatment efficacy, it is crucial to evaluate how psilocybin influences these cognitive domains.

Objectives: This meta-analysis aims to quantify the acute effects of psilocybin on executive functions and attention, while examining how dosage, timing of administration, cognitive domain, and task characteristics moderate these effects.

Methods: A systematic review and multilevel meta-analysis were conducted on empirical studies assessing psilocybin's acute effects on working memory, conflict monitoring, response inhibition, cognitive flexibility, and attention. Effect sizes for reaction time (RT) and accuracy (ACC) were calculated, exploring the effects of timing (on-peak defined as 90-180 min post-administration), dosage, cognitive function categories, and task sensitivity to executive functions as potential moderators.

Results: Thirteen studies (42 effect sizes) were included. In the acute phase, psilocybin increased RTs (Hedges' g = 1.13, 95% CI [0.57, 1.7]) and did not affect ACC (Hedges' g = -0.45, 95% CI [-0.93, 0.034]). Effects on RT were dose dependent. Significant between-study heterogeneity was found for both RT and ACC. Task sensitivity to executive functions moderated RT effects. Publication bias was evident, but the overall effect remained significant after adjustment for this.

Conclusions: Our meta-analysis shows that psilocybin impairs executive functions and results in a slowing down of RT. We discuss potential neurochemical mechanisms underlying the observed effects as well as implications for the safe use of psilocybin in clinical and experimental contexts.

References

Abramovitch A, Short T, Schweiger A . The C Factor: Cognitive dysfunction as a transdiagnostic dimension in psychopathology. Clin Psychol Rev. 2021; 86:102007. DOI: 10.1016/j.cpr.2021.102007. View

Adleman N, Menon V, Blasey C, White C, Warsofsky I, Glover G . A developmental fMRI study of the Stroop color-word task. Neuroimage. 2002; 16(1):61-75. DOI: 10.1006/nimg.2001.1046. View

Balaet M . Psychedelic Cognition-The Unreached Frontier of Psychedelic Science. Front Neurosci. 2022; 16:832375. PMC: 8989050. DOI: 10.3389/fnins.2022.832375. View

Barrett F, Carbonaro T, Hurwitz E, Johnson M, Griffiths R . Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: effects on cognition. Psychopharmacology (Berl). 2018; 235(10):2915-2927. PMC: 6162157. DOI: 10.1007/s00213-018-4981-x. View

Barrett F, Krimmel S, Griffiths R, Seminowicz D, Mathur B . Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention. Neuroimage. 2020; 218:116980. PMC: 10792549. DOI: 10.1016/j.neuroimage.2020.116980. View

Bogenschutz M, Ross S, Bhatt S, Baron T, Forcehimes A, Laska E . Percentage of Heavy Drinking Days Following Psilocybin-Assisted Psychotherapy vs Placebo in the Treatment of Adult Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Psychiatry. 2022; 79(10):953-962. PMC: 9403854. DOI: 10.1001/jamapsychiatry.2022.2096. View

Bonnieux J, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera M . Psilocybin's effects on cognition and creativity: A scoping review. J Psychopharmacol. 2023; 37(7):635-648. PMC: 10350723. DOI: 10.1177/02698811231179801. View

Burgess P, Veitch E, de Lacy Costello A, Shallice T . The cognitive and neuroanatomical correlates of multitasking. Neuropsychologia. 2000; 38(6):848-63. DOI: 10.1016/s0028-3932(99)00134-7. View

Calder A, Hasler G . Towards an understanding of psychedelic-induced neuroplasticity. Neuropsychopharmacology. 2022; 48(1):104-112. PMC: 9700802. DOI: 10.1038/s41386-022-01389-z. View

10.

Carhart-Harris R, Giribaldi B, Watts R, Baker-Jones M, Murphy-Beiner A, Murphy R . Trial of Psilocybin versus Escitalopram for Depression. N Engl J Med. 2021; 384(15):1402-1411. DOI: 10.1056/NEJMoa2032994. View

11.

Carter O, Burr D, Pettigrew J, Wallis G, Hasler F, Vollenweider F . Using psilocybin to investigate the relationship between attention, working memory, and the serotonin 1A and 2A receptors. J Cogn Neurosci. 2005; 17(10):1497-508. DOI: 10.1162/089892905774597191. View

12.

Chen E, Hsieh S . The effect of age on task switching: updated and extended meta-analyses. Psychol Res. 2023; 87(7):2011-2030. DOI: 10.1007/s00426-023-01794-z. View

13.

Chen J, Paul J, Reeve R . Manipulation of attention affects subitizing performance: A systematic review and meta-analysis. Neurosci Biobehav Rev. 2022; 139:104753. DOI: 10.1016/j.neubiorev.2022.104753. View

14.

Doss M, Madden M, Gaddis A, Nebel M, Griffiths R, Mathur B . Models of psychedelic drug action: modulation of cortical-subcortical circuits. Brain. 2021; 145(2):441-456. PMC: 9014750. DOI: 10.1093/brain/awab406. View

15.

Duman I, Ehmann I, Gonsalves A, Gultekin Z, Van den Berckt J, van Leeuwen C . The No-Report Paradigm: A Revolution in Consciousness Research?. Front Hum Neurosci. 2022; 16:861517. PMC: 9130851. DOI: 10.3389/fnhum.2022.861517. View

16.

Enriquez-Geppert S, Konrad C, Pantev C, Huster R . Conflict and inhibition differentially affect the N200/P300 complex in a combined go/nogo and stop-signal task. Neuroimage. 2010; 51(2):877-87. DOI: 10.1016/j.neuroimage.2010.02.043. View

17.

Evarts E, Landau W, FREYGANG Jr W, Marshall W . Some effects of lysergic acid diethylamide and bufotenine on electrical activity in the cat's visual system. Am J Physiol. 1955; 182(3):594-8. DOI: 10.1152/ajplegacy.1955.182.3.594. View

18.

Franklin M, Smallwood J, Schooler J . Catching the mind in flight: using behavioral indices to detect mindless reading in real time. Psychon Bull Rev. 2011; 18(5):992-7. DOI: 10.3758/s13423-011-0109-6. View

19.

Friedman N, Miyake A . Unity and diversity of executive functions: Individual differences as a window on cognitive structure. Cortex. 2016; 86:186-204. PMC: 5104682. DOI: 10.1016/j.cortex.2016.04.023. View

20.

Gouzoulis-Mayfrank E, Thelen B, Maier S, Heekeren K, Kovar K, Sass H . Effects of the hallucinogen psilocybin on covert orienting of visual attention in humans. Neuropsychobiology. 2002; 45(4):205-12. DOI: 10.1159/000063672. View